在选择性手术中管理失控出血:损害控制技术的作用
Atsushi Nanashima1, Takashi Wada1, Fumiaki Kawano1
1Division of Hepato-Biliary-Pancreas Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
International journal of surgery case reports
|February 21, 2025
概括
损伤控制手术 (DCS) 是一种在传统方法失败时在选择性手术期间大量出血的救生干预. 这种方法可以稳定出血性休克和凝血病患者,使复杂病例的结果有利.
科学领域:
- 手术瘤学手术瘤学
- 创伤外科 手术 创伤外科
- 肝胆道手术 肝胆道手术
背景情况:
- 选择性手术中的大量出血带来了重大挑战,往往超过了传统的静血手术的疗效,特别是不受控制的凝血病.
- 损伤控制手术 (DCS) 是创伤护理中一个公认的策略,用于管理出血性休克,凝血病,低温和酸性疾病.
- 在选择性环境中,DCS可以成为意外大量出血的关键干预措施,特别是在生命体征不稳定或腹内压力增加的患者中.
研究的目的:
- 评估损害控制外科手术 (DCS) 在选择性手术期间管理大量手术内出血的疗效.
- 提出案例研究,证明DCS在复杂的手术场景中的成功应用.
- 突出DCS作为在选修程序期间在意外紧急情况中拯救生命的措施的作用.
主要方法:
- 在选择性腹部手术 (结肠癌切除和肝脏切除) 期间出现两种明显的大量出血病例.
- 由于失控出血和血液动力学不稳定,在两种情况下都采用了涉及布包装和开放腹部管理的损害控制手术 (DCS).
- 进行了第二次外科手术,以解决残留出血并促进腹部闭合,其中一例使用了血管内气球阻塞大动脉.
主要成果:
- 两位患者,尽管最初大量出血和凝血病,但在DCS之后的手术干预中幸存下来.
- 案例1涉及上半腹静脉损伤的修复,患者在术后存活了9个月.
- 案例2证明了肝切除和DCS后成功的血液静止和没有肝衰竭的恢复.
结论:
- 在选择性手术期间大量出血和不受控制的凝血病时,传统的静血技术可能不足.
- 损伤控制手术 (DCS) 是一种有价值的,可能挽救生命的方法,用于在选择性手术环境中管理意想不到的大量出血和血液动力学不稳定.
- 在这些情况下,DCS的成功应用支持了其在复杂的选择性手术中的实用性,在复杂的选择性手术中,长时间的手术是不可行的,或者当传统方法失败时.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
34
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
34
Introduction to Hemostasis
5.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.0K
Epistaxis
118
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
118
Extrinsic and Intrinsic Pathways of Hemostasis
4.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.8K
Disorders of Hemostasis
680
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
680
Vascular Spasm
1.2K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.2K


